Press Releases | Alexion Pharmaceuticals, Inc

About Alexion
Patient Focus
Products
Research & Development
Responsibility
Careers
Select a Country
- North America
  - Canada
  - USA
- Latin America
  - Argentina
  - Brazil
  - Colombia
  - Mexico
- Europe, the Middle East & Africa
  - Alexion Europe
  - Belgium
  - Denmark
  - France
  - Germany
  - Ireland
  - Italy
  - Netherlands
  - Norway
  - Russia
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - UAE
  - UK
- Asia Pacific
  - Australia
  - China
  - India
  - Japan
Investors
News
Contact

Home
»
Newsroom
»
Press Releases

Press Releases

All News Releases

Alexion Names Paul Clancy Chief Financial Officer
June 13, 2017
HTML PDF
Alexion Announces Additions to Executive Leadership Team
June 1, 2017
HTML PDF
Alexion to Present at Upcoming Investor Conferences
May 30, 2017
HTML PDF
Alexion Announces Executive Leadership Changes
May 23, 2017
HTML PDF
Rady Children’s Institute for Genomic Medicine and Alexion Pharmaceuticals Partner to Speed the Diagnosis of Rare Genetic Disorders in Newborns
May 16, 2017
HTML PDF
Long-term Data Confirm Benefits of Treatment with Strensiq® (asfotase alfa) in Adolescents and Adults with Hypophosphatasia (HPP) Through Five Years
May 15, 2017
HTML PDF
Alexion Global Headquarters Earns Highest LEED® Green Building Certification
May 11, 2017
HTML PDF
Alexion to Present at the Bank of America Merrill Lynch 2017 Health Care Conference
May 9, 2017
HTML PDF
Alexion Reports First Quarter 2017 Results
April 27, 2017
HTML PDF
Alexion to Report First Quarter 2017 Results on Thursday, April 27, 2017
April 6, 2017
HTML PDF